Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Advanced NSCLC
NCT00005037Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Jan 2000
- Primary completion
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in non-small cell lung cancer (NSCLC), sponsored by Fox Chase Cancer Center. Started Jan 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005037.